ANTI-CD19

Clinical trials for ANTI-CD19 explained in plain language.

Never miss a new study

Get alerted when new ANTI-CD19 trials appear

Sign up with your email to follow new studies for ANTI-CD19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug budoprutug aims to boost platelets in ITP patients

Disease control Recruiting now

This study tests a new drug called budoprutug in 24 adults with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. Participants must have very low platelet counts despite prior treatments. The main goal is to check safet…

Matched conditions: ANTI-CD19

Phase: PHASE1, PHASE2 • Sponsor: Climb Bio, Inc. • Aim: Disease control

Last updated May 17, 2026 03:25 UTC

ANTI-CD19

Get alerted when new ANTI-CD19 trials appear

New drug budoprutug aims to boost platelets in ITP patients